|
|
||||||||
Articles |
This report describes essential requirements for the validation of a radioimmunoassay (RIA) for insulin-like growth factor-I (IGF-I) and presents solutions to some problems and pitfalls commonly observed. The preparation of IGF-I to be used as radioligand or standard has to be selected carefully since some IGF-I preparations are contaminated with variants which demonstrate different potencies for different antisera used in the RIA. Accurate assessment of IGF-I levels in blood plasma requires an efficient extraction method for the IGF-binding proteins (IGFBPs). Extraction methods to remove the influence of IGFBPs in the RIA were compared using blood plasma of considerable differences in IGF-I/IGFBP ratios. Acidification of plasma before column chromatography on Sephadex G-75 (G75) is generally considered to be the most reliable extraction method, but it is very time-consuming. The acid-ethanol extraction (AE) of plasma is not valid in many situations. Non-parallel displacement to the IGF-I standard was observed with AE-extracted plasma samples in the RIA. In addition, a comparison of IGF-I values obtained in the RIA after AE or G75 extraction of fetal ovine plasma has shown no significant correlation. We report an extraction technique based on a modified AE extraction followed by cryo-precipitation (AEC). AEC extraction on blood plasma reduced residual IGFBPs to a level that did not interfere in the assay. Furthermore, AEC-extracted plasma samples showed parallel displacement in the RIA to highly purified preparations of authentic IGF-I. We observed high correlations, with a slope close to unity, of IGF-I values obtained in the RIA using the AEC or G75 extraction for plasma from different species including adult and fetal sheep, rat, mouse and man. The AEC extraction provides a rapid and simple alternative to G75 extraction for blood plasma from a variety of species provided that high-affinity antisera are used for the RIA.
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
|
G. Keller, A. V. Schally, K. Groot, G. L. Toller, A. Havt, F. Koster, P. Armatis, G. Halmos, M. Zarandi, J. L. Varga, and J. B. Engel Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone PNAS, July 26, 2005; 102(30): 10628 - 10633. [Abstract] [Full Text] [PDF] |
||||
|
J. B. Engel, G. Keller, A. V. Schally, G. L. Toller, K. Groot, A. Havt, P. Armatis, M. Zarandi, J. L. Varga, and G. Halmos Inhibition of Growth of Experimental Human Endometrial Cancer by an Antagonist of Growth Hormone-Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3614 - 3621. [Abstract] [Full Text] [PDF] |
||||
|
B. C. Peterson, G. C. Waldbieser, and L. Bilodeau Effects of recombinant bovine somatotropin on growth and abundance of mRNA for IGF-I and IGF-II in channel catfish (Ictalurus punctatus) J Anim Sci, April 1, 2005; 83(4): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
|
C Vinoles, M Forsberg, G B Martin, C Cajarville, J Repetto, and A Meikle Short-term nutritional supplementation of ewes in low body condition affects follicle development due to an increase in glucose and metabolic hormones Reproduction, March 1, 2005; 129(3): 299 - 309. [Abstract] [Full Text] [PDF] |
||||
|
M. H. OLIVER, B. H. BREIER, P. D. GLUCKMAN, and J. E. HARDING Birth Weight Rather Than Maternal Nutrition Influences Glucose Tolerance, Blood Pressure, and IGF-I Levels in Sheep Pediatr. Res., September 27, 2002; 52(4): 516 - 524. [Abstract] [Full Text] [PDF] |
||||
|
J. van Doorn, C. M. Hoogerbrugge, J. G. Koster, R. J. Bloemen, K. Hoekman, A. H. Mudde, and S. C. van Buul-Offers Antibodies Directed against the E Region of Pro-Insulin-like Growth Factor-II Used to Evaluate Non-Islet Cell Tumor-induced Hypoglycemia Clin. Chem., October 1, 2002; 48(10): 1739 - 1750. [Abstract] [Full Text] [PDF] |
||||
|
D. Simmons and B. H. Breier Fetal Overnutrition in Polynesian Pregnancies and in Gestational Diabetes May Lead to Dysregulation of the Adipoinsular Axis in Offspring Diabetes Care, September 1, 2002; 25(9): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
|
P. U. Freda Somatostatin Analogs in Acromegaly J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3013 - 3018. [Full Text] [PDF] |
||||
|
B. Dawson-Hughes and S. S Harris Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women Am. J. Clinical Nutrition, April 1, 2002; 75(4): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
|
M. Katsumata, S. Kawakami, Y. Kaji, R. Takada, and M. J. Dauncey Differential Regulation of Porcine Hepatic IGF-I mRNA Expression and Plasma IGF-I Concentration by a Low Lysine Diet J. Nutr., April 1, 2002; 132(4): 688 - 692. [Abstract] [Full Text] [PDF] |
||||
|
F. H. BLOOMFIELD, B. H. BREIER, and J. E. HARDING Fate of 125I-IGF-I Administered into the Amniotic Fluid of Late-Gestation Fetal Sheep Pediatr. Res., March 1, 2002; 51(3): 361 - 369. [Abstract] [Full Text] [PDF] |
||||
|
F. H. Bloomfield, M. K. Bauer, P. L. Van Zijl, P. D. Gluckman, and J. E. Harding Amniotic IGF-I supplements improve gut growth but reduce circulating IGF-I in growth-restricted fetal sheep Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E259 - 269. [Abstract] [Full Text] [PDF] |
||||
|
Y. Iwanaga, Y. Kihara, T. Yoneda, T. Aoyama, and S. Sasayama Modulation of in vivo cardiac hypertrophy with insulin-like growth factor-1 and angiotensin-converting enzyme inhibitor: relationship between change in myosin isoform and progression of left ventricular dysfunction J. Am. Coll. Cardiol., August 1, 2000; 36(2): 635 - 642. [Abstract] [Full Text] [PDF] |
||||
|
V. Chandrashekar, A. Bartke, C. A. Awoniyi, C. H. Tsai-Morris, M. L. Dufau, L. D. Russell, and J. J. Kopchick Testicular Endocrine Function in GH Receptor Gene Disrupted Mice Endocrinology, August 1, 2001; 142(8): 3443 - 3450. [Abstract] [Full Text] [PDF] |
||||
|
L. Wang and M. L. Adamo Cyclic Adenosine 3',5'-Monophosphate Inhibits Insulin-Like Growth Factor I Gene Expression in Rat Glioma Cell Lines: Evidence for Regulation of Transcription and Messenger Ribonucleic Acid Stability Endocrinology, July 1, 2001; 142(7): 3041 - 3050. [Abstract] [Full Text] [PDF] |
||||
|
W. Kwong, A. Wild, P Roberts, A. Willis, and T. Fleming Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension Development, January 10, 2000; 127(19): 4195 - 4202. [Abstract] [PDF] |
||||
|
I. Chatzistamou, A. V. Schally, J. L. Varga, K. Groot, P. Armatis, R. Busto, and G. Halmos Antagonists of Growth Hormone-Releasing Hormone and Somatostatin Analog RC-160 Inhibit the Growth of the OV-1063 Human Epithelial Ovarian Cancer Cell Line Xenografted into Nude Mice J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2144 - 2152. [Abstract] [Full Text] |
||||
|
R. J. Hunter, V. B. Patel, J. P. Miell, H. J. Wong, J. S. Marway, P. J. Richardson, and V. R. Preedy Diarrhea Reduces the Rates of Cardiac Protein Synthesis in Myofibrillar Protein Fractions in Rats In Vivo J. Nutr., May 1, 2001; 131(5): 1513 - 1519. [Abstract] [Full Text] |
||||
|
P. D. Raposinho, E. Castillo, V. Dalleves, P. Broqua, F. P. Pralong, and M. L. Aubert Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes Endocrinology, December 1, 2000; 141(12): 4419 - 4427. [Abstract] [Full Text] |
||||
|
M. J. Toth, A. Tchernof, C. J. Rosen, D. E. Matthews, and E. T. Poehlman Regulation of Protein Metabolism in Middle-Aged, Premenopausal Women: Roles of Adiposity and Estradiol J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1382 - 1387. [Abstract] [Full Text] |
||||
|
J. Khosravi, A. Diamandi, J. Mistry, and R. G. Krishna The High Molecular Weight Insulin-Like Growth Factor-Binding Protein Complex: Epitope Mapping, Immunoassay, and Preliminary Clinical Evaluation J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2826 - 2833. [Abstract] [Full Text] |
||||
|
E. S. Kurland, F. K. W. Chan, C. J. Rosen, and J. P. Bilezikian Normal Growth Hormone Secretory Reserve in Men with Idiopathic Osteoporosis and Reduced Circulating Levels of Insulin-Like Growth Factor-I J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2576 - 2579. [Abstract] [Full Text] |
||||
|
N. Buchs, J.-P. Bonjour, and R. Rizzoli Renal Tubular Reabsorption of Phosphate Is Positively Related to the Extent of Bone Metastatic Load in Patients with Prostate Cancer J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1535 - 1541. [Abstract] [Full Text] |
||||
|
E. S. Kurland, C. J. Rosen, F. Cosman, D. McMahon, F. Chan, E. Shane, R. Lindsay, D. Dempster, and J. P. Bilezikian Insulin-Like Growth Factor-I in Men with Idiopathic Osteoporosis J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2799 - 2805. [Abstract] [Full Text] |
||||
|
J. Rabinovici, N. A. Cataldo, P. Dandekar, S. M. Rosenthal, S. E. Gargosky, N. Gesundheit, and M. C. Martin Adjunctive Growth Hormone during Ovarian Hyperstimulation Increases Levels of Insulin-Like Growth Factor Binding Proteins in Follicular Fluid: A Randomized, Placebo-Controlled, Cross-Over Study J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1171 - 1176. [Abstract] [Full Text] |
||||
|
V. Chandrashekar, A. Bartke, K. T. Coschigano, and J. J. Kopchick Pituitary and Testicular Function in Growth Hormone Receptor Gene Knockout Mice Endocrinology, March 1, 1999; 140(3): 1082 - 1088. [Abstract] [Full Text] |
||||
|
V. Locatelli, G. Rossoni, F. Schweiger, A. Torsello, V. De Gennaro Colonna, M. Bernareggi, R. Deghenghi, E. E. Müller, and F. Berti Growth Hormone-Independent Cardioprotective Effects of Hexarelin in the Rat Endocrinology, September 1, 1999; 140(9): 4024 - 4031. [Abstract] [Full Text] |
||||
|
E. Svanberg, L. Powell-Braxton, C. Ohlsson, H. Zachrisson, and K. Lundholm The Role of the Growth Hormone/Insulin-Like Growth Factor I Axis in Stimulation of Protein Synthesis in Skeletal Muscles Following Oral Refeeding Endocrinology, December 1, 1998; 139(12): 4906 - 4910. [Abstract] [Full Text] |
||||
|
S. Zaina, R. V. S. Newton, M. R. Paul, and C. F. Graham Local Reduction of Organ Size in Transgenic Mice Expressing a Soluble Insulin-Like Growth Factor II/Mannose-6-Phosphate Receptor Endocrinology, September 1, 1998; 139(9): 3886 - 3895. [Abstract] [Full Text] |
||||
|
V. Chandrashekar and A. Bartke The Role of Growth Hormone in the Control of Gonadotropin Secretion in Adult Male Rats Endocrinology, March 1, 1998; 139(3): 1067 - 1074. [Abstract] [Full Text] |
||||
|
M. Tzanela, C. Wagner, and G. Shaffer Tannenbaum Recombinant Human Growth Hormone-Binding Protein Fails to Enhance the in Vivo Bioactivity of Human Growth Hormone in Normal Rats Endocrinology, December 1, 1997; 138(12): 5316 - 5324. [Abstract] [Full Text] |
||||
|
J. E. Harding, P. C. Evans, and P. D. Gluckman Maternal Growth Hormone Treatment Increases Placental Diffusion Capacity But Not Fetal or Placental Growth in Sheep Endocrinology, December 1, 1997; 138(12): 5352 - 5358. [Abstract] [Full Text] |
||||
|
C. Heinrichs, M. Colli, J. A. Yanovski, L. Laue, N. A. Gerstl, A. D. Kramer, J. A. Uyeda, and J. Baron Effects of Fasting on the Growth Plate: Systemic and Local Mechanisms Endocrinology, December 1, 1997; 138(12): 5359 - 5365. [Abstract] [Full Text] |
||||
|
B. Tönshoff, D. R. Powell, D. Zhao, S. K. Durham, M. E. Coleman, H. M. Domené, W. F. Blum, R. C. Baxter, L. C. Moore, and F. J. Kaskel Decreased Hepatic Insulin-Like Growth Factor (IGF)-I and Increased IGF Binding Protein-1 and -2 Gene Expression in Experimental Uremia Endocrinology, March 1, 1997; 138(3): 938 - 946. [Abstract] [Full Text] |
||||
|
E. Melián, B. Velasco, R. Barrios, and F. Sanchez-Franco Basal and Growth Hormone-Induced Hepatic Messenger Ribonucleic Acid Expression of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Is Independent of Hyperinsulinemia and Increased Energy Status in the Genetically Obese Zucker Rat Endocrinology, March 1, 1997; 138(3): 1066 - 1071. [Abstract] [Full Text] |
||||
|
P. A. Piosik, M. van Groenigen, J. van Doorn, F. Baas, and J. J. M. de Vijlder Effects of Maternal Thyroid Status on Thyroid Hormones and Growth in Congenitally Hypothyroid Goat Fetuses during the Second Half of Gestation Endocrinology, January 1, 1997; 138(1): 5 - 11. [Abstract] [Full Text] |
||||
|
K. D. Laugero and G. P. Moberg Energetic response to repeated restraint stress in rapidly growing mice Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E33 - 43. [Abstract] [Full Text] |
||||
|
K. D. Laugero and G. P. Moberg Summation of behavioral and immunological stress: metabolic consequences to the growing mouse Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E44 - 49. [Abstract] [Full Text] |
||||
|
G. R. Adams, S. A. McCue, P. W. Bodell, M. Zeng, and K. M. Baldwin Effects of spaceflight and thyroid deficiency on hindlimb development. I. Muscle mass and IGF-I expression J Appl Physiol, March 1, 2000; 88(3): 894 - 903. [Abstract] [Full Text] |
||||
|
H. Kiaris, A. V. Schally, J. L. Varga, K. Groot, and P. Armatis From the Cover: Growth hormone-releasing hormone: An autocrine growth factor for small cell lung carcinoma PNAS, December 21, 1999; 96(26): 14894 - 14898. [Abstract] [Full Text] [PDF] |
||||
|
G. R. Adams, F. Haddad, and K. M. Baldwin Time course of changes in markers of myogenesis in overloaded rat skeletal muscles J Appl Physiol, November 1, 1999; 87(5): 1705 - 1712. [Abstract] [Full Text] |
||||
|
M. Pendergrass, E. Fazioni, D. Collins, and R. A. DeFronzo Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E345 - 350. [Abstract] |
||||
|
N. Lamharzi, A. V. Schally, M. Koppan, and K. Groot Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors PNAS, July 21, 1998; 95(15): 8864 - 8868. [Abstract] [Full Text] [PDF] |
||||
|
R. M. Sapolsky and E. M. Spencer Insulin-like growth factor I is suppressed in socially subordinate male baboons Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1346 - 1351. [Abstract] [Full Text] |
||||
|
C. E. Perrone, D. Fenwick-Smith, and H. H. Vandenburgh Collagen and Stretch Modulate Autocrine Secretion of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Proteins from Differentiated Skeletal Muscle Cells J. Biol. Chem., February 3, 1995; 270(5): 2099 - 2106. [Abstract] [Full Text] [PDF] |
||||
|
M. Brink, J. Wellen, and P. Delafontaine Angiotensin II Causes Weight Loss and Decreases Circulating Insulin-like Growth Factor I in Rats through a Pressor-independent Mechanism J. Clin. Invest., June 1, 1996; 97(11): 2509 - 2516. [Abstract] [Full Text] |
||||
|
A. Jungwirth, A. V. Schally, J. Pinski, K. Groot, P. Armatis, and G. Halmos Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal�adenocarcinoma PNAS, May 27, 1997; 94(11): 5810 - 5813. [Abstract] [Full Text] [PDF] |
||||
|
C. E. H. Stewart and P. Rotwein Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts J. Biol. Chem., May 10, 1996; 271(19): 11330 - 11338. [Abstract] [Full Text] [PDF] |
||||
HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |